Viewing Study NCT03208218


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-02-27 @ 12:48 AM
Study NCT ID: NCT03208218
Status: COMPLETED
Last Update Posted: 2017-07-06
First Post: 2017-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
Sponsor: Samyang Biopharmaceuticals Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module